UNI-EN 105:Current report 105 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 105 | / | 2013 | | ||||||
Date of issue: | 2013-08-05 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report 105 re insiders transactions | |||||||||||
Official market - legal basis | |||||||||||
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
The Board of Directors of Sopharma AD (the “Company") announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares in the Company: Date and time of the Operation Number settlement of shares Unit price (BGN) 31.7.2013 Sale 2 000 3.3150 31.7.2013 Sale 3 000 3.3190 31.7.2013 Sale 5 000 3.3200 31.7.2013 Sale 231 3.3200 31.7.2013 Sale 300 3.3200 31.7.2013 Sale 4 200 3.3200 31.7.2013 Sale 269 3.3200 31.7.2013 Sale 5 000 3.3200 1.8.2013 Sale 5 000 3.3220 1.8.2013 Sale 5 000 3.3220 1.8.2013 Sale 1 000 3.3220 1.8.2013 Sale 5 000 3.3250 1.8.2013 Sale 5 000 3.3250 1.8.2013 Sale 5 000 3.3250 1.8.2013 Sale 6 000 3.3250 1.8.2013 Sale 6 000 3.3250 1.8.2013 Sale 4 000 3.3250 1.8.2013 Sale 4 000 3.3250 1.8.2013 Sale 6 000 3.3250 1.8.2013 Sale 4 700 3.3280 1.8.2013 Sale 5 300 3.3280 1.8.2013 Sale 4 000 3.3290 1.8.2013 Sale 900 3.3200 1.8.2013 Sale 4 600 3.3200 2.8.2013 Sale 2 000 3.3290 2.8.2013 Sale 1 000 3.3290 2.8.2013 Sale 4 000 3.3400 2.8.2013 Sale 2 000 3.3400 2.8.2013 Sale 6 000 3.3400 2.8.2013 Sale 4 650 3.3450 2.8.2013 Sale 1 000 3.3450 2.8.2013 Sale 6 000 3.3400 2.8.2013 Sale 4 700 3.3450 2.8.2013 Sale 350 3.3450 2.8.2013 Sale 6 000 3.3450 2.8.2013 Sale 3 000 3.3450 2.8.2013 Sale 6 000 3.3450 2.8.2013 Sale 5 200 3.3450 2.8.2013 Sale 300 3.3450 2.8.2013 Sale 6 000 3.3450 2.8.2013 Sale 5 500 3.3450 2.8.2013 Sale 3 300 3.3450 2.8.2013 Sale 6 000 3.3450 2.8.2013 Sale 6 000 3.3450 2.8.2013 Sale 4 750 3.3450 5.8.2013 Sale 5 000 3.3300 5.8.2013 Sale 51 3.3300 5.8.2013 Sale 6 000 3.3300 5.8.2013 Sale 6 000 3.3300 5.8.2013 Sale 6 000 3.3300 5.8.2013 Sale 59 3.3300 5.8.2013 Sale 70 3.3300 5.8.2013 Sale 1 000 3.3300 5.8.2013 Sale 820 3.3300 5.8.2013 Sale 5 180 3.3300 5.8.2013 Sale 6 300 3.3300 5.8.2013 Sale 5 330 3.3300 5.8.2013 Sale 520 3.3300 5.8.2013 Sale 6 300 3.3300 5.8.2013 Sale 6 000 3.3200 5.8.2013 Sale 6 000 3.3200 5.8.2013 Sale 700 3.3200 5.8.2013 Sale 5 000 3.3200 5.8.2013 Sale 5 900 3.3180 5.8.2013 Sale 100 3.3180 5.8.2013 Sale 5 000 3.3180 5.8.2013 Sale 4 500 3.3180 5.8.2013 Sale 500 3.3180 6.8.2013 Sale 5 400 3.3300 6.8.2013 Sale 600 3.3300 6.8.2013 Sale 6 500 3.3250 6.8.2013 Sale 5 000 3.3250 6.8.2013 Sale 6 000 3.3250 6.8.2013 Sale 500 3.3250 6.8.2013 Sale 90 3.3250 6.8.2013 Sale 250 3.3250 6.8.2013 Sale 4 300 3.3250 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 105 re insiders transactions.doc Current report 105 re insiders transactions.doc | Current report 105 re insiders transactions |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2013-08-05 | Ognian Donev | Executive director |
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.